A novel cervical cancer suppressor 3 (CCS-3) interacts with the BTB domain of PLZF and inhibits the cell growth by inducing apoptosis

FEBS Letters

Volumn 580, Issue 17, 2006, Pages 4073-4080

  Rho, Seung Bae ^a   Park, Young Gyo ^a   Park, Kyoungsook ^a   Lee, Seung Hoon ^a   Lee, Je Ho ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

BTB POZ domain; Cell cycle arrest; Cervical cancer suppressor 3; Cyclin A2; PLZF

Indexed keywords

CERVICAL CANCER SUPPRESSOR 3 PROTEIN; COMPLEMENTARY DNA; CYCLIN A; ISOPROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE PROGRESSION; CELL GROWTH; CONTROLLED STUDY; DNA LIBRARY; EMBRYO; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; IN VITRO STUDY; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TWO HYBRID SYSTEM; UTERINE CERVIX CANCER; YEAST;

APOPTOSIS; CYCLIN A; DNA-BINDING PROTEINS; EMBRYONIC DEVELOPMENT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; OVARY; PEPTIDE ELONGATION FACTOR 1; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; TWO-HYBRID SYSTEM TECHNIQUES; UTERINE CERVICAL NEOPLASMS;

MAMMALIA;

EID: 33745866880     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.06.047     Document Type: Article

References (46)

1. Bardwell V.J., and Treisman R. The POZ domain: a conserved protein-protein interaction motif. Genes Dev. 8 (1994) 1664-1677
2. Li J.Y., English M.A., Ball H.J., Yeyati P.L., Waxman S., and Licht J.D. Sequence-specific DNA binding and transcriptional regulation by the promyelocytic leukemia zinc finger protein. J. Biol. Chem. 272 (1997) 22447-22455
3. Sitterlin D., Tiollais P., and Transy C. The RAR alpha-PLZF chimera associated with acute promyelocytic leukemia has retained a sequence-specific DNA-binding domain. Oncogene 14 (1997) 1067-1074
4. Parrado A., Robledo M., MoyaQuiles M.R., Marin L.A., Chomienne C., Padua R.A., and AlvarezLopez M.R. The promyelocytic leukemia zinc finger protein downregulates apoptosis and expression of the proapoptotic BID protein in lymphocytes. Proc. Natl. Acad. Sci. USA 101 (2004) 1898-1903
5. Ball H.J., Melnick A., Shaknovich R., Kohanski R.A., and Licht J.D. The promyelocytic leukemia zinc finger (PLZF) protein binds DNA in a high molecular weight complex associated with cdc2 kinase. Nucleic Acids Res. 27 (1999) 4106-4113
6. Yeyati P.L., Shaknovich R., Boterashvili S., Li J., Ball H.J., Waxman S., NasonBurchenal K., Dmitrovsky E., Zelent A., and Licht J.D. Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A. Oncogene 18 (1999) 925-934
7. Melnick A., Ahmad K.F., Arai S., Polinger A., Ball H., Borden K.L., Carlile G.W., Prive G.G., and Licht J.D. In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions. Mol. Cell. Biol. 20 (2000) 6550-6567
8. Kang S.I., Chang W.J., Cho S.G., and Kim I.Y. Modification of promyelocytic leukemia zinc finger protein (PLZF) by SUMO-1 conjugation regulates its transcriptional repressor activity. J. Biol. Chem. 278 (2003) 51479-51483
9. Hong S.H., David G., Wong C.W., Dejean A., and Privalsky M.L. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA 94 (1997) 9028-9033
10. David G., Alland L., Hong S.H., Wong C.W., DePinho R.A., and Dejean A. Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein. Oncogene 16 (1998) 2549-2556
11. Grignani F., Matteis S.D., Nervi C., Tomassoni N.L., Gelmetti V., Cioce M., Fanelli M., Ruthardt M., Ferrara F.F., Zamir I., Seiser C., Lazar M.A., Minucci S., and Pelicci P.G. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 391 (1998) 815-818
12. Guidez F., Ivins S., Zhu J., Soderstrom M., Waxman S., and Zelent A. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood 91 (1998) 2634-2642
13. Reid A., Gould A., Brand N., Cook M., Strutt P., Li J., Licht J., Waxman S., Krumlauf R., and Zelent A. Leukemia translocation gene, PLZF, is expressed with a speckled nuclearpattern in early hematopoietic progenitors. Blood 86 (1995) 4544-4552
14. Horowitz H., and Berg C.A. The Drosophila pipsqueak gene encodes a nuclear BTB-domain-containing protein required early in oogenesis. Development 122 (1996) 1859-1871
15. Dent A.L., Shaffer A.L., Yu D., Allman D., and Staudt L.M. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276 (1997) 589-592
16. Lai Z.C., and Li Y. Tramtrack69 is positively and autonomously required for Drosophila photoreceptor development. Genetics 152 (1999) 299-305
17. Staudt L.M., Dent A.L., Shaffer A.L., and Yu X. Regulation of lymphocyte cell fate decisions and lymphomagenesis by BCL-6. Int. Rev. Immunol. 18 (1999) 381-403
18. Barna M., Hawe N., Niswander L., and Pandolfi P.P. Plzf regulates limb and axial skeletal patterning. Nat. Genet. 25 (2000) 166-172
19. Melnick A.M., Westendorf J.J., Polinger A., Carlile G.W., Arai S., Ball H.J., Lutterbach B., Hiebert S.W., and Licht J.D. The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein. Mol. Cell. Biol. 20 (2000) 2075-2086
20. UsuiAoki K., Ito H., UiTei K., Takahashi K., Lukacsovich T., Awano W., Nakata H., Piao Z.F., Nilson E.E., Tomida J., and Yamamoto D. Formation of the male-specific muscle in female Drosophila by ectopic fruitless expression. Nat. Cell Biol. 2 (2000) 500-506
21. Melnick A., Carlile G., Ahmad K.F., Kiang C.L., Corcoran C., Bardwell V., Prive G.G., and Licht J.D. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors. Mol. Cell. Biol. 22 (2002) 1804-1818
22. Lee D.K., Suh D., Edenberg H.J., and Hur M.W. POZ domain transcription factor, FBI-1,represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with DNA binding activity of Sp1. J. Biol. Chem. 277 (2002) 26761-26768
23. Ye B.H., Lista F., LoCoco F., Knowles D.M., Offit K., Chaganti R.S., and DallaFavera R. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 262 (1993) 747-750
24. Gaidano G., LoCoco F., Ye B.H., Shibata D., Levine A.M., Knowles D.M., and DallaFavera R. Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma: association with diffuse large-cell subtype. Blood 84 (1994) 397-402
25. LoCoco F., Ye B.H., Lista F., Corradini P., Offit K., Knowles D.M., Chaganti R.S., and DallaFavera R. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood 83 (1994) 1757-1759
26. Negrutskii B.S., and El'skaya A.V. Eukaryotic translation elongation factor 1 alpha: structure, expression, functions, and possible role in aminoacyl-tRNA channeling. Prog. Nucleic Acid Res. Mol. Biol. 60 (1998) 47-78
27. Ejiri S. Cloning and expression of Bombyx mori silk gland elongation factor 1gamma in Escherichia coli. Biosci. Biotechnol. Biochem. 66 (2002) 558-565
28. Calado A., Treichel N., Muller E.C., Otto A., and Kutay U. Exportin-5-mediated nuclear export of eukaryotic elongation factor 1A and tRNA. EMBO J. 21 (2002) 6216-6224
29. Ito H., Fukada Y., Murata K., and Kimura A. Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 153 (1983) 163-168
30. Rho S.B., Lee K.H., Kim J.W., Shiba K., Jo Y.J., and Kim S. Interaction between human tRNA synthetases involves repeated sequence elements. Proc. Natl. Acad. Sci. USA 93 (1996) 10128-10133
31. Rho S.B., Chun T., Lee S.H., Park K., and Lee J.H. The interaction between E-tropomodulin and thymosin β-10 rescues tumor cells from thymosin β-10 mediated apoptosis by restoring actin architecture. FEBS Lett. 557 (2004) 57-63
32. Han S.H., Jeon J.H., Ju H.R., Jung U., Kim K.Y., Yoo H.S., Lee Y.H., Song K.S., Hwang H.M., Na Y.S., Yang Y., Lee K.N., and Choi I. VDUP1 upregulated by TGF-β1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression. Oncogene 22 (2003) 4035-4046
33. Ross D.T., Scherf U., Eisen M.B., Perou C.M., Rees C., Spellman P., Iyer V., Jeffrey S.S., VandeRijn M., Waltham M., Pergamenschikov A., Lee J.C., Lashkari D., Shalon D., Myers T.G., Weinstein J.N., Botstein D., and Brown P.O. Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet. 24 (2000) 227-235
34. Corn P.G., and El-Deiry W.S. Derangement of growth and differentiation control in oncogenesis. BioEssays 24 (2002) 83-90
35. Clurman B.E., and Roberts J.M. Cell cycle and cancer. J. Natl. Cancer Inst. 87 (1995) 1499-1501
36. Sherr C.J. Cancer cell cycles. Science 274 (1996) 1672-1677
37. Vousden K.H., and Lu X. Live or let die: the cell's response to p53. Nat. Rev. Cancer 2 (2002) 594-604
38. Park K., Kim K., Rho S.B., Choi K., Kim D., Oh S.H., Park J., Lee S.H., and Lee J.H. Homeobox Msx1 interacts with p53 tumor suppressor and inhibits tumor growth by inducing apoptosis. Cancer Res. 65 (2005) 749-757
39. Rabbitts T.H. Translocations, master genes, and differences between the origins of acute and chronic leukemias. Cell 67 (1991) 641-644
40. Licht J.D., Shaknovich R., English M.A., Melnick A., Li J.Y., Reddy J.C., Dong S., Chen S.J., Zelent A., and Waxman S. Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia. Oncogene 12 (1996) 323-336
41. Bektas M., Nurten R., Gurel Z., Sayers Z., and Bermek E. Interactions of eukaryotic elongation factor 2 with actin: a possible link between protein synthetic machinery and cytoskeleton. FEBS Lett. 356 (1994) 89-93
42. Condeelis J. Elongation factor 1 alpha, translation and the cytoskeleton. Trends Biochem. Sci. 20 (1995) 169-170
43. Gopalkrishnam R.V., Su Z.Z., Goldstein N.I., and Fisher P.B. Translational infidelity and human cancer: role of the PTI-1 oncogene. Int. J. Biochem. Cell. Biol. 31 (1999) 151-162
44. Edmonds B.T., Wyckoff J., Yeung Y.G., Wang Y., Stanley E.R., Jones J., Segall J., and Condeelis J. Elongation factor-1 alpha is an overexpressed actin binding protein in metastatic rat mammary adenocarcinoma. J. Cell Sci. 109 (1996) 2705-2714
45. Kato M.V., Sato H., Nagayoshi M., and Ikawa Y. Upregulation of the elongation factor-1alpha gene by p53 in association with death of an erythroleukemic cell line. Blood 90 (1997) 1373-1378
46. Kato M.V. The mechanisms of death of an erythroleukemic cell line by p53: involvement of the microtubule and mitochondria. Leukemia Lymphoma 33 (1999) 181-186